Welcome to the EPA 2022 Interactive Programme 

Session Description:

We are on the cusp of a paradigm shift with the emerging field of precision psychiatry. Research in this area is aimed at improving understanding of psychiatric illnesses by leveraging insights from many techniques and accounting for patient individuality. The ultimate goal is to positively impact clinical practice and transform the lives of patients living with mental health conditions. With the concept of precision psychiatry as a backdrop, the Psychiatric Ratings using Intermediate Stratified Markers (PRISM) project was born. This session will take you through the PRISM journey—from conception through completion of PRISM 1 and launch of PRISM 2—and highlight how this project is taking meaningful steps to translate the idea of precision psychiatry into clinical practice. The PRISM project used social withdrawal as a primary focus as it represents an unmet need in the treatment of mental health disorders and can be particularly burdensome for patients. This session will introduce you to an innovative approach to monitoring social function and walk you through a live demonstration of the novel technology, providing a tangible example of how it may be used as a scalable digital biomarker for stratifying patients, and how it applies to the transdiagnostic approach.